Mitochondrial Dysfunction Therapeutics

Mitochondrial Dysfunction Therapeutics is a pharmacological intervention strategy that specifically targets and ameliorates impaired mitochondrial function in neurodegenerative diseases by restoring bioenergetic homeostasis, reducing oxidative stress, and preventing mitochondrial-mediated apoptotic signaling.

744

Publications

41.8K

Citations

5K

Authors

1.4K

Institutions

Publications per year

2017–2026

445

Authors

5K

  1. NC
    Nipon Chattipakorn

    Chiang Mai University, Thailand

    13 publications · 1.1K citations

    12

    h-index

  2. GP
    Gunter P. Eckert

    Goethe University Frankfurt, Germany

    9 publications · 522 citations

    9

    h-index

  3. SC
    Siriporn C. Chattipakorn

    Chiang Mai University, Thailand

    8 publications · 690 citations

    8

    h-index

  4. MP
    Michael P. Murphy

    MRC Mitochondrial Biology Unit, United Kingdom

    7 publications · 2.2K citations

    7

    h-index

  5. AN
    Ae Nim Pae

    Korea Institute of Science and Technology, South Korea

    6 publications · 163 citations

    6

    h-index

1–5 of 5K

Venues

  1. Mitochondrion

    18 publications · 784 citations

    16

    h-index

  2. Molecular Neurobiology

    14 publications · 882 citations

    14

    h-index

  3. PubMed

    Repository · 11 publications · 625 citations

    11

    h-index

  4. Scientific Reports

    11 publications · 474 citations

    11

    h-index

  5. Experimental Neurology

    10 publications · 857 citations

    10

    h-index

1–5